Ray Kall is a seasoned professional in market access and oncology, currently serving as Senior Director of Managed Markets East at BridgeBio since November 2023. Kall previously held the position of Executive Director of National, Federal, and Regional Accounts at AVEO Oncology, where significant accomplishments included leading the development of a Market Access team and achieving remarkable access for the company’s first oncology product. Prior experience also includes roles in Sanofi Genzyme as National Account Director for Oncology/Transplant, and extensive experience with Novo Nordisk in various leadership roles. Kall's educational qualifications include a Bachelor of Science in Animal Science from The University of Georgia.
This person is not in any teams
This person is not in any offices